Diabetes Care, Vol 17, Issue 4 275-283, Copyright © 1994 by American Diabetes Association

ARTICLES

Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes

TA Buchanan, SL Kjos, MN Montoro, PY Wu, NG Madrilejo, M Gonzalez, V Nunez, PM Pantoja and A Xiang
Department of Medicine, Los Angeles County and University of Southern California Medical Center.

OBJECTIVE--To determine whether fetal ultrasound early in the third trimester can identify Latina with mild gestational diabetes mellitus (GDM) whose fetuses are at risk for macrosomia and, if so, whether maternal insulin therapy can reduce that risk. RESEARCH DESIGN AND METHODS--Study subjects included 303 consecutive women with GDM and a fasting serum glucose level < 5.8 mM on diet therapy who had a fetal ultrasound between 29 and 33 weeks gestation. Of the women, 98 (32%) had a fetal AC > or = 75th percentile for gestational age, and 59 women completed a randomized trial of diet therapy (n = 29) or diet plus twice daily insulin (n = 30). Maternal nutrient levels were assessed by meal tolerance testing (MTT) before and during therapy and by capillary glucose monitoring four to seven times a day. Birth weights corrected for gestational age and neonatal glycemia and skin folds were the primary outcome variables compared between treatment groups. RESULTS--Diet and diet-plus-insulin groups were well matched for maternal age, prepregnancy relative weight, weight gain during pregnancy, and glycemia at entry. Insulin therapy reduced maternal capillary (P < 0.005) and MTT (P < 0.001) glucose levels and prevented a diet-associated rise in MTT triglyceride levels (P < 0.002). Gestational age at delivery was similar in insulin- and diet-treated groups (39.6 +/- 0.2 vs. 39.5 +/- 0.2 weeks). Birth weights (3,647 +/- 67 vs. 3,878 +/- 84 g; P < 0.02), the prevalence of large-for-gestational age infants (13 vs. 45%, P < 0.02), and neonatal skin-fold measurements at three sites (P < 0.005) were reduced in the insulin-treated group. Rates of transient neonatal hypoglycemia were low in both treatment groups (14 and 18%, respectively) and did not differ significantly between groups. CONCLUSIONS--Fetal ultrasound early in the third trimester identified women with mild GDM whose infants were at high risk for fetal macrosomia in the absence of standard glycemic criteria for insulin therapy. Insulin treatment reduced the macrosomia, indicating that fetal ultrasound can be used to guide metabolic therapy in pregnancies complicated by mild GDM.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. M. Catalano, A. Thomas, L. Huston-Presley, and S. B. Amini Phenotype of Infants of Mothers with Gestational Diabetes Diabetes Care, July 1, 2007; 30(Supplement_2): S156 - S160. [Full Text] [PDF]

				M. Hod and Y. Yogev Goals of Metabolic Management of Gestational Diabetes: Is it all about the sugar? Diabetes Care, July 1, 2007; 30(Supplement_2): S180 - S187. [Full Text] [PDF]

				S. L. Kjos and U. M. Schaefer-Graf Modified Therapy for Gestational Diabetes Using High-Risk and Low-Risk Fetal Abdominal Circumference Growth to Select Strict Versus Relaxed Maternal Glycemic Targets Diabetes Care, July 1, 2007; 30(Supplement_2): S200 - S205. [Full Text] [PDF]

				J. D.L. Dupak and A. L. Trujillo Ultrasound Surveillance in Pregnancy Complicated by Diabetes Diabetes Spectr, April 1, 2007; 20(2): 89 - 93. [Abstract] [Full Text] [PDF]

				U. M. Schaefer-Graf Randomized Trial Evaluating a Predominately Fetal Growth-Based Strategy to Guide Management of Gestational Diabetes in Caucasian Women: Response to Kitzmiller Diabetes Care, August 1, 2004; 27(8): 2091 - 2092. [Full Text] [PDF]

				U. M. Schaefer-Graf A Randomized Trial Evaluating a Predominantly Fetal Growth-Based Strategy to Guide Management of Gestational Diabetes in Caucasian Women: Response to Amiel and Blott Diabetes Care, July 1, 2004; 27(7): 1848 - 1849. [Full Text]

				U. M. Schaefer-Graf, S. L. Kjos, O. H. Fauzan, K. J. Buhling, G. Siebert, C. Buhrer, B. Ladendorf, J. W. Dudenhausen, and K. Vetter A Randomized Trial Evaluating a Predominately Fetal Growth-Based Strategy to Guide Management of Gestational Diabetes in Caucasian Women Diabetes Care, February 1, 2004; 27(2): 297 - 302. [Abstract] [Full Text] [PDF]

				T. A. Buchanan and S. L. Kjos Counterpoint: Glucose Monitoring in Gestational Diabetes: Lots of heat, not much light Diabetes Care, March 1, 2003; 26(3): 948 - 949. [Full Text] [PDF]

				S. Daniells, B. F. S. Grenyer, W. S. Davis, K. J. Coleman, J.-A. P. Burgess, and R. G. Moses Gestational Diabetes Mellitus: Is a diagnosis associated with an increase in maternal anxiety and stress in the short and intermediate term? Diabetes Care, February 1, 2003; 26(2): 385 - 389. [Abstract] [Full Text] [PDF]

				S. C. Brody, R. Harris, and K. Lohr Screening for Gestational Diabetes: A Summary of the Evidence for the U.S. Preventive Services Task Force Obstet. Gynecol., February 1, 2003; 101(2): 380 - 392. [Abstract] [Full Text] [PDF]

				S. L. Kjos, U. Schaefer-Graf, S. Sardesi, R. K. Peters, A. Buley, A. H. Xiang, J. D. Bryne, C. Sutherland, M. N. Montoro, and T. A. Buchanan A Randomized Controlled Trial Using Glycemic Plus Fetal Ultrasound Parameters Versus Glycemic Parameters to Determine Insulin Therapy in Gestational Diabetes With Fasting Hyperglycemia Diabetes Care, November 1, 2001; 24(11): 1904 - 1910. [Abstract] [Full Text] [PDF]

				S Virjee, S Robinson, and D G Johnston Screening for diabetes in pregnancy J R Soc Med, January 10, 2001; 94(10): 502 - 509. [Full Text] [PDF]

				J. L. Ecker, M. A. Mascola, L. E. Riley, S. L. Kjos, and T. A. Buchanan Gestational Diabetes N. Engl. J. Med., March 23, 2000; 342(12): 896 - 897. [Full Text]

				S. L. Kjos and T. A. Buchanan Gestational Diabetes Mellitus N. Engl. J. Med., December 2, 1999; 341(23): 1749 - 1756. [Full Text] [PDF]

				T. A. Buchanan and S. L. Kjos Gestational Diabetes: Risk or Myth? J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1854 - 1857. [Full Text]

				R. K. Bansal, J. L. Ecker, R. K. Laros, J.M. Miles, S.W. Coppack, T. A. Buchanan, S. L. Kjos, M. N. Montoro, M. de Veciana, M. A. Morgan, et al. Blood Glucose Monitoring in Gestational Diabetes Mellitus N. Engl. J. Med., February 29, 1996; 334(9): 598 - 599. [Full Text]